RT Journal Article
SR Electronic
T1 677 Phase II trial assessing safety, efficacy and immune correlates of heterologous prime-boost with pBI-11 (IM) and TA-HPV (IM) plus pembrolizumab for advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A768
OP A768
DO 10.1136/jitc-2023-SITC2023.0677
VO 11
IS Suppl 1
A1 Gibson, Michael K
A1 Savvides, Panayiotis
A1 Worden, Francis
A1 Heimann-Nichols, Ellen
A1 Wu, TC
A1 Roden, Richard
A1 Chang, Yung-Nien
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A768.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.